Ingenol mebutate to treat lentigo maligna of the head (face and scalp): A prospective, multicenter, single-arm phase 2 trial indicates no benefit

J Am Acad Dermatol. 2020 Mar;82(3):731-733. doi: 10.1016/j.jaad.2019.07.035. Epub 2019 Jul 17.
No abstract available

Publication types

  • Clinical Trial, Phase II
  • Letter
  • Multicenter Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Diterpenes / therapeutic use*
  • Facial Neoplasms / drug therapy
  • Female
  • Head and Neck Neoplasms / drug therapy*
  • Humans
  • Hutchinson's Melanotic Freckle / drug therapy*
  • Male
  • Middle Aged
  • Prospective Studies
  • Scalp*
  • Skin Neoplasms / drug therapy*
  • Treatment Outcome

Substances

  • 3-ingenyl angelate
  • Diterpenes